Guy Ungerechts

501 Smyth Road
Ottawa, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications

Hierarchical classification of immune cell transcriptomes at population-scale.

Hierarchical classification of immune cell transcriptomes at population-scale.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026

Hierarchical classification of immune cell transcriptomes at population-scale.

Hierarchical classification of immune cell transcriptomes at population-scale.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026

From monoclonal to polyfunctional immunotherapy: Reprogramming CAR-T-cell therapy with oncolytic viruses in B-cell malignancies.

From monoclonal to polyfunctional immunotherapy: Reprogramming CAR-T-cell therapy with oncolytic viruses in B-cell malignancies.

Journal: HemaSphere
Published: May 24, 2026

In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocol.

In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocol.

Journal: PLoS computational biology
Published: February 02, 2026

Harnessing natural RNA triplex elements found in lncRNAs MALAT1 and NEAT1 for engineering of novel riboswitch platforms.

Harnessing natural RNA triplex elements found in lncRNAs MALAT1 and NEAT1 for engineering of novel riboswitch platforms.

Journal: Nucleic acids research
Published: December 23, 2025

Development of a tetracycline-inducible programmed ribosomal frameshifting platform for sensitive regulation of mammalian gene expression.

Development of a tetracycline-inducible programmed ribosomal frameshifting platform for sensitive regulation of mammalian gene expression.

Journal: Nucleic acids research
Published: September 08, 2025

Oncolytic adenoviruses encoding bispecific T cell engagers or a novel trispecific T cell engager for dual-targeting of c-MET and EGFR.

Oncolytic adenoviruses encoding bispecific T cell engagers or a novel trispecific T cell engager for dual-targeting of c-MET and EGFR.

Journal: Molecular therapy. Oncology
Published: June 13, 2025

Oncolytic viruses as anticancer agents: clinical progress and remaining challenges.

Oncolytic viruses as anticancer agents: clinical progress and remaining challenges.

Journal: Lancet (London, England)
Published: November 12, 2024

H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma.

H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma.

Journal: Cancers
Published: June 25, 2024

The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics.

The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics.

Journal: Pathogens (Basel, Switzerland)
Published: January 11, 2024

Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells.

Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells.

Journal: Pathogens (Basel, Switzerland)
Published: February 27, 2023

Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference.

Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference.

Journal: Viruses
Published: December 31, 2022
Showing 1-12 of 48

Last Updated: 09/26/2026